Sign in

CIK 0000727510 · Non-accelerated filer<br>Smaller reporting company

Viskase Holdings, Inc.

Sign in to watch
Ticker
VISK
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
222372868
Phone
(630) 874-0700
Business address
333 EAST BUTTERFIELD ROAD, SUITE 400, LOMBARD, IL, 60148
Former names
ENZON PHARMACEUTICALS, INC., ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICAL INC, ENZON INC
  1. 3 Insider Initial Statement of Ownership
  2. 4 Open-market sale Director sold 55,926 shares at an average $1.72 ($96,082)
  3. 4 Grant or award VP and General Counsel acquired 4,686 shares (grant or award)
  4. 4 Grant or award VP, Clinical Development acquired 3,748 shares (grant or award)
  5. 4 Grant or award SVP, R&D Program Management acquired 2,343 shares (grant or award)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Grant or award Interim PEO and Interim COO acquired 24,500 shares (grant or award)
  13. 4 Open-market sale Director sold 5,820 shares at $6.58 ($38,308)
  14. 4 Open-market sale Director sold 1,933 shares at $6.58 ($12,720)
  15. 4 Grant or award Director acquired 10,669 shares (grant or award)
  16. 4 Grant or award Director acquired 10,669 shares (grant or award)
  17. 4 Grant or award Director acquired 10,669 shares (grant or award)
  18. 4 Grant or award Director acquired 10,669 shares (grant or award)
  19. 4 Grant or award Director acquired 18,670 shares (grant or award)
  20. 4 Grant or award Director acquired 21,338 shares (grant or award)

Page 3 of 28 · 560 filings